International Oncology Network - Cancer & Hematology News
Share 'Phase III Front-line Trial Planned with Brentuximab Vedotin in Advanced Stage Hodgkin Lymphoma Patients'
Interim results from a phase I clinical trial of brentuximab vedotin(SGN-35, Adcetris™, Seattle Genetics/Millennium: The Takeda Oncology Company) in combination with chemotherapy for the treatment of newly diagnosed advanced stage Hodgkin lymphoma (HL) patients were presented Anas Younes, MD, Professor, Department of Lymphoma/Myeloma, Division of Cancer Medicine, The University of Texas MD Anders…
You can share this blog post in two ways…
© 2013 Created by Peter Hofland, PhD.
